EUVIMEDEUVIMED entdecken
Open Access

Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation

Kamal P Pandey, Branka Divović, Farjana Rashid, Lalit K Golani, Rok Cerne, Nicolas M Zahn, Michelle Jean Meyer, Leggy A Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L Smith, Xingjie Ping und 6 weitere

The Journal of Pharmacology and Experimental Therapeutics · 2023

DOI: 10.1124/jpet.122.001362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2023. Verfasst von Kamal P Pandey und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (K.P.P., F.R., L.K.G., N.M.Z., M.J.M., L.A.A., D.S.…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To provide back-up compounds to support the development of the GABAA receptor (GABAAR) potentiator KRM-II-81, three novel analogs were designed: replacing the pyridinyl with 2'-Cl-phenyl (FR-II-60), changing the positions of the N and O atoms in the oxazole ring with addition of an ethyl group (KPP-III-34 and KPP-III-51), or substituting a Br atom for the ethynyl of KRM-II-81 (KPP-III-34). The compounds bound to brain GABAARs. Intraperitoneal administration of FR-II-60 and KPP-III-34 produced anticonvulsant activity in mice [maximal electroshock (MES)-induced seizures or 6 Hz-induced seizures], whereas KPP-III-51 did not. Although all compounds were orally bioavailable, structural changes reduced the plasma and brain (FR-II-60 and KPP-III-51) exposures relative to KRM-II-81. Oral administration of each compound produced dose-dependent increases in the latency for both clonic and tonic seizures and the lethality induced by pentylenetetrazol (PTZ) in mice. Since KPP-III-34 produced the highest brain area under the curve (AUC) exposures, it was selected for further profiling. Oral administration of KPP-III-34 suppressed seizures in corneal-kindled mice, hippocampal paroxysmal discharges in mesial temporal lobe epileptic mice, and PTZ-induced convulsions in rats. Only transient sensorimotor impairment was observed in mice, and doses of KPP-III-34 up to 500 mg/kg did not produce impairment in rats. Molecular docking studies demonstrated that all compounds displayed a reduced propensity for binding to α1His102 compared with the sedating compound alprazolam; the bromine-substituted KPP-III-34 achieved the least interaction. Overall, these findings document the oral bioavailability and anticonvulsant efficacy of three novel analogs of KRM-II-81 with reduced sedative effects. SIGNIFICANCE STATEMENT: A new non-sedating compound, KRM-II-81, with reduced propensity for tolerance is moving into clinical development. Three new analogs were orally bioavailable, produced anticonvulsant effects in rodents, and displayed low sensorimotor impairment. KPP-III-34 demonstrated efficacy in models of pharmacoresistant epilepsy. Docking studies demonstrated a low propensity for compound binding to the α1His102 residue implicated in sedation. Thus, three additional structures have been added to the list of non-sedating imidazodiazepine anticonvulsants that could serve as backups in the clinical development of KRM-II-81.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyRatsMiceAnimalsMolecular Docking SimulationSeizuresOxazolesReceptors, GABA-APentylenetetrazoleElectroshock

Substanzen

AnticonvulsantsKRM-II-81OxazolesReceptors, GABA-APentylenetetrazole

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (K.P.P., F.R., L.K.G., N.M.Z., M.J.M., L.A.A., D.S., M.Y.M., V.V.N.P.B.T., J.M.C., J.M.W.); kppandey@uwm.edu witkinconsul…
  • Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia (B.D., M.M.S.); kppandey@uwm.edu witkinconsult@gmail.com.
  • Laboratory of Antiepileptic Drug Discovery, St. Vincent's Hospital, Indianapolis, Indiana (R.C., J.L.S., J.M.W.); kppandey@uwm.edu witkinconsult@gmail.com.
  • Department of Anatomy and Cell BiologyIndiana University/Purdue University, Indianapolis, Indiana (R.C., X.P., X.J.); kppandey@uwm.edu witkinconsult@gmail.com.
  • Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia (R.C.); and RespireRx Pharmaceuticals Inc., Glen Rock, New Jersey (A.L., J.M.C., J.M.W.) kppandey@uwm.edu witkinconsult@gmail.com.
  • Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (K.P.P., F.R., L.K.G., N.M.Z., M.J.M., L.A.A., D.S., M.Y.M., V.V.N.P.B.T., J.M.C., J.M.W.).

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Pandey, K. P., Divović, B., Rashid, F., Golani, L. K., Cerne, R., Zahn, N. M., Meyer, M. J., Arnold, L. A., Sharmin, D., Mian, M. Y., Smith, J. L., Ping, X., Jin, X., Lippa, A., Tiruveedhula, V. V. N. P. B., Cook, J. M., Savić, M. M., & Witkin, J. M. (2023). Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.122.001362

Vancouver

Pandey KP, Divović B, Rashid F, Golani LK, Cerne R, Zahn NM, et al. Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation. The Journal of Pharmacology and Experimental Therapeutics. 2023. doi:10.1124/jpet.122.001362

BibTeX
@article{Pandey2023,
  author = {Pandey, Kamal P and Divović, Branka and Rashid, Farjana and Golani, Lalit K and Cerne, Rok and Zahn, Nicolas M and Meyer, Michelle Jean and Arnold, Leggy A and Sharmin, Dishary and Mian, Md Yeunus and Smith, Jodi L and Ping, Xingjie and Jin, Xiaoming and Lippa, Arnold and Tiruveedhula, V V N Phani Babu and Cook, James M and Savić, Miroslav M and Witkin, Jeffrey M},
  title = {Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2023},
  doi = {10.1124/jpet.122.001362}
}
Kostenlos starten →